Foghorn Therapeutics FHTX Q1 2025 earnings
Reported May 14, 2025 · Before market open
Revenue$6.0MMiss by $287.7K
EPS-$0.30In line
Revenue estimate$6.2M
EPS estimate-$0.30
Next report
Aug 4, 2026 (In 6 days)Revenue estimate$7.0M
EPS estimate-$0.23
Versus estimates
Revenue
Ask the moment Foghorn Therapeutics reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Foghorn Therapeutics report Q1 2025 earnings?
- Foghorn Therapeutics (FHTX) reported Q1 2025 earnings on May 14, 2025 before market open.
- What were Foghorn Therapeutics's Q1 2025 revenue and EPS?
- Foghorn Therapeutics reported revenue of $6.0M and eps of $-0.30 for Q1 2025.
- Did Foghorn Therapeutics beat estimates in Q1 2025?
- Revenue missed the consensus estimate of $6.2M by $287.7K. EPS beat the consensus estimate of $-0.30 by $0.00.
- How did Foghorn Therapeutics's Q1 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 17.9% from $5.1M a year earlier and eps grew 49.2% from $-0.59.
- Where can I find Foghorn Therapeutics's Q1 2025 SEC filings?
- You can read the 10-Q periodic report (0001628280-25-025312) directly on SEC EDGAR. The filing index links above go to sec.gov.